Frankfurt - Delayed Quote EUR

Affluent Medical SA (0JZ.F)

Compare
1.3450
-0.0300
(-2.18%)
As of 3:29:02 PM GMT+2. Market Open.
Loading Chart for 0JZ.F
  • Previous Close 1.3750
  • Open 1.3150
  • Bid 1.2850 x --
  • Ask 1.4950 x --
  • Day's Range 1.3150 - 1.3750
  • 52 Week Range 1.2150 - 1.9100
  • Volume 653
  • Avg. Volume 15
  • Market Cap (intraday) 53.078M
  • Beta (5Y Monthly) 0.64
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Affluent Medical SA develops minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is based in Aix-en-Provence, France.

www.affluentmedical.com

66

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0JZ.F

View More

Performance Overview: 0JZ.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

0JZ.F
6.32%
CAC 40 (^FCHI)
1.17%

1-Year Return

0JZ.F
19.22%
CAC 40 (^FCHI)
10.52%

3-Year Return

0JZ.F
66.11%
CAC 40 (^FCHI)
8.36%

5-Year Return

0JZ.F
82.27%
CAC 40 (^FCHI)
75.57%

Compare To: 0JZ.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0JZ.F

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    54.26M

  • Enterprise Value

    70.30M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    2.07

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -17.51%

  • Return on Equity (ttm)

    -52.40%

  • Revenue (ttm)

    1.29M

  • Net Income Avi to Common (ttm)

    -17.04M

  • Diluted EPS (ttm)

    -0.5400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    915k

  • Total Debt/Equity (mrq)

    67.15%

  • Levered Free Cash Flow (ttm)

    -1.44M

Research Analysis: 0JZ.F

View More

Company Insights: 0JZ.F

Research Reports: 0JZ.F

View More

People Also Watch